The Chemokines: Biology Of The Inflammatory Peptide Supergene Family Ii (Advances In Experimental Medicine And Biology, 351),Used

The Chemokines: Biology Of The Inflammatory Peptide Supergene Family Ii (Advances In Experimental Medicine And Biology, 351),Used

In Stock
SKU: SONG1461362830
Brand: Springer
Sale price$86.41 Regular price$123.44
Save $37.03
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

The first symposium in this series was held at the Royal College of Surgeons of England in December 1988 and was entitled 'Novel Neutrophil Stimulating Peptides'. That symposium successfully brought together the majority of laboratories working in the area of interleukin8 and related peptides; see Immunology Today 10: 146147 (1989). The Second International Symposium on Chemotactic Cytokines was held at the same venue in June 1990, and a muchincreased attendance reflected the accelerating pace of work in the area of these chemotactic cytokines. The proceedings of that meeting were published in Advances in Experimental Medicine and Biology, vol. 305 (1991). The rapid advances made in the field of chemotactic cytokines over the last 18 months necessitated a third Symposium in this series to collate and place in perspective an explosion of new data. The Third International Symposium on Chemotactic Cytokines was held between August 31 and September 1, 1992 in BadenbeiWien, Austria. However, the lack of a clear nomenclature system was creating some confusion in the area, especially as new factors continue to be discovered and classified as family members. In the past, these inflammatory mediators had been placed arbitrarily under the broad heading of 'intercrines' or 'chemotactic cytokines' with no clear classification guidelines to follow. This nomenclature issue was addressed at the Symposium, where investigators in the field were invited to reach a consensus regarding a collective name for these mediators. The resulting decision was to identify the major family as chemokines, to replace all previous terms.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed